These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 36869958)

  • 1. Assessing the impact of COVID-19 on economic recovery: role of potential regulatory responses and corporate liquidity.
    Lin R; Liu X; Liang Y
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):53977-53996. PubMed ID: 36869958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of COVID-19 government support and its consequences for firm liquidity and solvency.
    Lalinsky T; Pál R
    Struct Chang Econ Dyn; 2022 Jun; 61():305-335. PubMed ID: 35317527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studying corporate liquidity and regulatory responses for economic recovery in COVID-19 crises.
    Chang L; Gan X; Mohsin M
    Econ Anal Policy; 2022 Dec; 76():211-225. PubMed ID: 36043124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small firms and the COVID-19 insolvency gap.
    Dörr JO; Licht G; Murmann S
    Small Bus Econ (Dordr); 2022; 58(2):887-917. PubMed ID: 38624681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Covid-19 on corporate solvency and possible policy responses in the EU.
    Mirza N; Rahat B; Naqvi B; Rizvi SKA
    Q Rev Econ Finance; 2023 Feb; 87():181-190. PubMed ID: 32982131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financing constraints and firm-level responses to the COVID-19 pandemic: International evidence.
    Khan SU
    Res Int Bus Finance; 2022 Jan; 59():101545. PubMed ID: 34580554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Firms' COVID-19 Pandemic Exposure and Corporate Cash Policy: Evidence from China.
    He Z; Suardi S; Wang K; Zhao Y
    Econ Model; 2022 Nov; 116():105999. PubMed ID: 36032988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Asymmetric Impact of COVID-19: A Novel Approach to Quantifying Financial Distress across Industries.
    Archanskaia E; Canton E; Hobza A; Nikolov P; Simons W
    Eur Econ Rev; 2023 Jun; ():104509. PubMed ID: 37360582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Credit constraints and the severity of COVID-19 impact: Empirical evidence from enterprise surveys.
    Zhang D; Sogn-Grundvåg G
    Econ Anal Policy; 2022 Jun; 74():337-349. PubMed ID: 35281616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cui bono? Large-scale evidence on the impact of COVID-19 policy measures on listed firms.
    Haimann M; Kaserer C; Ljubicic K
    Q Rev Econ Finance; 2023 Jun; 89():228-243. PubMed ID: 37132001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lending relationships and a corporate liquidity shortage: Evidence from the COVID-19 shock in Japan.
    Tsuruta D
    MDE Manage Decis Econ; 2022 Mar; ():. PubMed ID: 35571608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SME viability in the COVID-19 recovery.
    McCann F; McGeever N; Yao F
    Small Bus Econ (Dordr); 2023 Jan; ():1-22. PubMed ID: 38625252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lockdown, employment adjustment, and financial frictions.
    Lastauskas P
    Small Bus Econ (Dordr); 2022; 58(2):919-942. PubMed ID: 38624870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 Pandemic and Corporate Liquidity: The Role of SOEs' Trade Credit Response.
    Wang X; Yu J
    J Int Money Finance; 2023 Jun; ():102901. PubMed ID: 38620114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is cash the panacea of the COVID-19 pandemic: Evidence from corporate performance.
    Zheng M
    Financ Res Lett; 2022 Mar; 45():102151. PubMed ID: 35221815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Pandemics on Corporate Innovation: Evidence From the Chinese Firms.
    Zhang C; Hu Y; Huang L; Huang Y
    Front Public Health; 2021; 9():780348. PubMed ID: 34805086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental performance and firm financing during COVID-19 outbreaks: Evidence from SMEs.
    Wellalage NH; Kumar V; Hunjra AI; Al-Faryan MAS
    Financ Res Lett; 2022 Jun; 47():102568. PubMed ID: 34840534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The COVID-19 outbreak and corporate cash-holding levels: Evidence from China.
    Zhou D; Zhou H; Bai M; Qin Y
    Front Psychol; 2022; 13():942210. PubMed ID: 36324775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promote Green Innovation in Manufacturing Enterprises in the Aspect of Government Subsidies in China.
    Sun X; Tang J; Li S
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of COVID-19 on trade flows: Measuring their impact through government policy responses.
    Barbero J; de Lucio JJ; Rodríguez-Crespo E
    PLoS One; 2021; 16(10):e0258356. PubMed ID: 34644312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.